These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 25588686)

  • 21. The management of patients with atrial fibrillation and dronedarone's place in therapy.
    Cohen M; Boiangiu C
    Adv Ther; 2011 Dec; 28(12):1059-77. PubMed ID: 22170292
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of dronedarone: a review of randomized trials.
    Christiansen CB; Torp-Pedersen C; Køber L
    Expert Opin Drug Saf; 2010 Jan; 9(1):189-99. PubMed ID: 20001756
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dronedarone in atrial fibrillation: the aftermath of the PALLAS trial.
    Salam AM
    Expert Rev Cardiovasc Ther; 2012 Nov; 10(11):1345-9. PubMed ID: 23244355
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The use of dronedarone for recurrent ventricular tachycardia: a case report and review of the literature.
    Rizkallah J; Kuriachan V; Brent Mitchell L
    BMC Res Notes; 2016 Jul; 9():370. PubMed ID: 27461025
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiarrhythmic drugs for atrial fibrillation: focus on dronedarone.
    Krishnamoorthy S; Lip GY
    Expert Rev Cardiovasc Ther; 2009 May; 7(5):473-81. PubMed ID: 19419255
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: rate and rhythm management.
    Gillis AM; Verma A; Talajic M; Nattel S; Dorian P;
    Can J Cardiol; 2011; 27(1):47-59. PubMed ID: 21329862
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Two unusual cases of toxic epidermal necrolysis.
    Yung A; Agnew K; Snow J; Oliver F
    Australas J Dermatol; 2002 Feb; 43(1):35-8. PubMed ID: 11869206
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety profile of dronedarone in clinical practice. Results of the Magdeburg Dronedarone Registry (MADRE study).
    Said SM; Esperer HD; Kluba K; Genz C; Wiedemann AK; Boenigk H; Herold J; Schmeisser A; Braun-Dullaeus RC
    Int J Cardiol; 2013 Sep; 167(6):2600-4. PubMed ID: 22781508
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rhythm- and rate-controlling effects of dronedarone in patients with atrial fibrillation (from the ATHENA trial).
    Page RL; Connolly SJ; Crijns HJ; van Eickels M; Gaudin C; Torp-Pedersen C; Hohnloser SH;
    Am J Cardiol; 2011 Apr; 107(7):1019-22. PubMed ID: 21296333
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dronedarone: is it time to turn it down?
    Lin L; Bai R
    Expert Opin Drug Saf; 2013 Jan; 12(1):5-8. PubMed ID: 23137162
    [No Abstract]   [Full Text] [Related]  

  • 31. [Between guidelines and regulatory decisions: the odyssey of dronedarone].
    De Ponti F; Mugelli A
    G Ital Cardiol (Rome); 2012 May; 13(5):334-6. PubMed ID: 22539138
    [No Abstract]   [Full Text] [Related]  

  • 32. [Dronedarone: the new antiarrythmic agent?].
    Brachmann J; Sinha AM
    Herzschrittmacherther Elektrophysiol; 2009 Jun; 20(2):73-5. PubMed ID: 19517208
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dronedarone for atrial fibrillation: the limited reliability of clinical practice guidelines.
    Iannone P; Haupt E; Flego G; Truglio P; Minardi M; Clarke S; Magrini N
    JAMA Intern Med; 2014 Apr; 174(4):625-9. PubMed ID: 24535046
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dronedarone-induced digoxin toxicity: new drug, new interactions.
    Vallakati A; Chandra PA; Pednekar M; Frankel R; Shani J
    Am J Ther; 2013; 20(6):e717-9. PubMed ID: 21519214
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Worsening heart failure in the setting of dronedarone initiation.
    Coons JC; Plauger KM; Seybert AL; Sokos GG
    Ann Pharmacother; 2010 Sep; 44(9):1496-500. PubMed ID: 20628043
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dronedarone therapy in atrial fibrillation: a summary of recent controlled trials.
    Duray GZ; Schmitt J; Hohnloser SH
    J Cardiovasc Pharmacol Ther; 2010 Dec; 15(4 Suppl):19S-23S. PubMed ID: 20472812
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An individual patient-based meta-analysis of the effects of dronedarone in patients with atrial fibrillation.
    Hohnloser SH; Connolly SJ; John Camm A; Halperin JL; Radzik D
    Europace; 2014 Aug; 16(8):1117-24. PubMed ID: 24728270
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost-effectiveness of dronedarone in atrial fibrillation: results for Canada, Italy, Sweden, and Switzerland.
    Åkerborg Ö; Nilsson J; Bascle S; Lindgren P; Reynolds M
    Clin Ther; 2012 Aug; 34(8):1788-802. PubMed ID: 22770643
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dronedarone for the control of ventricular rate in permanent atrial fibrillation: the Efficacy and safety of dRonedArone for the cOntrol of ventricular rate during atrial fibrillation (ERATO) study.
    Davy JM; Herold M; Hoglund C; Timmermans A; Alings A; Radzik D; Van Kempen L;
    Am Heart J; 2008 Sep; 156(3):527.e1-9. PubMed ID: 18760136
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-standard dose dronedarone in treating atrial fibrillation patients.
    Huang JH; Lin YK; Hsieh MH; Chen SA; Chen YJ
    Int J Cardiol; 2014; 172(1):e214-6. PubMed ID: 24461984
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.